Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
Spike has bacteria (~LPS) that causes symptoms like toxic shock syndrome Ivermectin seems to bind to the bacteria in this study pre-covod
Ivermectin works wonderfully well in all these nations except the US.
That’s 40% of planets population. 85% reduced mortality.
Actual in-real-life scoreboard beats a study every time.
Results:
Ivermectin improved mouse survival rate induced by a lethal dose of LPS. In addition, ivermectin significantly decreased the production of TNF-α, IL-1ß and IL-6 in vivo and in vitro. Furthermore, ivermectin suppressed NF-kB translocation induced by LPS.
Conclusions:
The results indicate that ivermectin may inhibit LPS-induced production of inflammatory cytokines by blocking NF-kB pathway and improve LPS-induced survival in mice. This finding might provide a new strategy for the treatment of endotoxemia and associated inflammation.